Skip to main content
Erschienen in: Current Cardiovascular Imaging Reports 1/2010

01.02.2010 | Clinical Trial Report

The ATHEROMA Study: Rapid Anti-inflammatory Effects of High-Dose Statin Pharmacotherapy Illuminated by Molecular MRI

verfasst von: William J. Hucker, Farouc A. Jaffer

Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Excerpt

Tang TY, Howarth SPS, Miller SR, et al.: The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol 2009, 53:2039–2050. …
Literatur
1.
Zurück zum Zitat Schwartz GG, Olsson AG, Ezekowitz MD, et al.; Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) Study Investigators: Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001, 285:1711–1718.CrossRefPubMed Schwartz GG, Olsson AG, Ezekowitz MD, et al.; Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) Study Investigators: Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001, 285:1711–1718.CrossRefPubMed
2.
Zurück zum Zitat Ray KK, Cannon CP, McCabe CH, et al.; PROVE IT-TIMI 22 Investigators: Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 2005, 46:1405–1410.CrossRefPubMed Ray KK, Cannon CP, McCabe CH, et al.; PROVE IT-TIMI 22 Investigators: Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 2005, 46:1405–1410.CrossRefPubMed
3.
Zurück zum Zitat Lindsay AC, Choudhury RP: Form to function: current and future roles for atherosclerosis imaging in drug development. Nat Rev Drug Discov 2008, 7:517–529.CrossRefPubMed Lindsay AC, Choudhury RP: Form to function: current and future roles for atherosclerosis imaging in drug development. Nat Rev Drug Discov 2008, 7:517–529.CrossRefPubMed
4.
Zurück zum Zitat Tahara N, Kai H, Ishibashi M, et al.: Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006, 48:1825–1831.CrossRefPubMed Tahara N, Kai H, Ishibashi M, et al.: Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006, 48:1825–1831.CrossRefPubMed
6.
Zurück zum Zitat Kooi ME, Cappendijk VC, Cleutjens KB, et al.: Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003, 107:2453–2458.CrossRefPubMed Kooi ME, Cappendijk VC, Cleutjens KB, et al.: Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003, 107:2453–2458.CrossRefPubMed
7.
Zurück zum Zitat Fayad ZA, Razzouk L, Briley-Saebo KC, Mani V: Iron oxide magnetic resonance imaging for atherosclerosis therapeutic evaluation: still “rusty”? J Am Coll Cardiol 2009, 53:2051–2052.CrossRefPubMed Fayad ZA, Razzouk L, Briley-Saebo KC, Mani V: Iron oxide magnetic resonance imaging for atherosclerosis therapeutic evaluation: still “rusty”? J Am Coll Cardiol 2009, 53:2051–2052.CrossRefPubMed
8.
Zurück zum Zitat Weissleder R, Elizondo G, Wittenberg J, et al.: Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990, 175:489–493.PubMed Weissleder R, Elizondo G, Wittenberg J, et al.: Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990, 175:489–493.PubMed
9.
Zurück zum Zitat Jaffer FA, Libby P, Weissleder R: Molecular imaging of cardiovascular disease. Circulation 2007, 116:1052–1061.CrossRefPubMed Jaffer FA, Libby P, Weissleder R: Molecular imaging of cardiovascular disease. Circulation 2007, 116:1052–1061.CrossRefPubMed
10.
Zurück zum Zitat Jaffer FA, Vinegoni C, John MC, et al.: Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation 2008, 118:1802–1809.CrossRefPubMed Jaffer FA, Vinegoni C, John MC, et al.: Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation 2008, 118:1802–1809.CrossRefPubMed
Metadaten
Titel
The ATHEROMA Study: Rapid Anti-inflammatory Effects of High-Dose Statin Pharmacotherapy Illuminated by Molecular MRI
verfasst von
William J. Hucker
Farouc A. Jaffer
Publikationsdatum
01.02.2010
Verlag
Current Science Inc.
Erschienen in
Current Cardiovascular Imaging Reports / Ausgabe 1/2010
Print ISSN: 1941-9066
Elektronische ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-009-9003-2

Weitere Artikel der Ausgabe 1/2010

Current Cardiovascular Imaging Reports 1/2010 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.